Oncosil Medical Ltd
ASX:OSL
Oncosil Medical Ltd
ASX:OSL
Price:
0.005 AUD
Market Closed
Updated:
May 2, 2024
Oncosil Medical Ltd
Cash from Financing Activities
|
Oncosil Medical Ltd
Cash from Financing Activities Peer Comparison
Comparables:
ADO
PIQ
CTE
GSS
E
EZZ
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncosil Medical Ltd
ASX:OSL
|
Cash from Financing Activities
AU$9.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-2%
|
|
|
Anteotech Ltd
ASX:ADO
|
Cash from Financing Activities
AU$1.4m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Cash from Financing Activities
AU$3.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Cash from Financing Activities
-AU$809.8k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Cash from Financing Activities
AU$7.5m
|
CAGR 3-Years
90%
|
CAGR 5-Years
172%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Cash from Financing Activities
-AU$761.7k
|
CAGR 3-Years
-84%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Oncosil Medical Ltd's Cash from Financing Activities?
Cash from Financing Activities
9.4m
AUD
9.4m
AUD
Based on the financial report for Dec 31, 2023, Oncosil Medical Ltd's Cash from Financing Activities amounts to 9.4m AUD.
What is Oncosil Medical Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-2%
-2%
Over the last year, the Cash from Financing Activities growth was 3%. The average annual Cash from Financing Activities growth rates for Oncosil Medical Ltd have been -19% over the past three years , -10% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
